The WasteWatcher: The Staff Blog of Citizens Against Government Waste

Medicare Part B

Adopting Foreign Countries’ Price Controls: A Really Bad Idea

Citizens Against Government Waste (CAGW) was troubled and mystified when the Trump administration issued an advanced notice of proposed rulemaking that would change Medicare Part B reimbursement for outpatient drugs from the Average Sales Price (ASP) plus 6 percent to instead a reimbursement system based on what other countries pay for the same drugs.

Taxpayers and Patients Win Second Round on 340B Drug Discount Rule

In January, Citizens Against Government Waste (CAGW) discussed a court case concerning a November 1, 2017 Centers for Medicare and Medicaid Services (CMS) final rule for Medicare Part B that will lower costs to taxpayers and Medicare beneficiaries for certain outpatient pharmaceuticals purchased under the 340B drug discount program.  It is expected the rule will save Medicare beneficiarie

Taxpayers and Patients Win First Round on 340B Drug Discount Rule

Citizens Against Government Waste (CAGW) discussed in its November 7, 2017 WasteWatcher blog, a Centers for Medicare and Medicaid Services (CMS) final rule for Medicare Part B that will lower costs to taxpayers and Medicare beneficiaries for certain outpatient pharmaceuticals purchased under the 340B drug discount program.

Sign Up for Email Updates!Click Here!

View Archives

Posts by Author

Posts by Tag

Big Government (152) Obamacare (76) Waste (74) Congress (71) Healthcare (70) Budget (69) Uncategorized (56) Telecommunications (50) Internet (48) Technology (46) Debt (43) Deficit (43)